Allison John W II sold $406K of HOMB

Allison John W II sold 13,500 shares of HOME BANCSHARES INC (HOMB) at $30.06 ($0.41M total) on 2026-10-29.

Original reporting
SEC EDGAR · Allison John W II
Published Oct 30, 2026, 6:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 6:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$HOMB
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The transaction represents a small portion of the insider's holdings and is unlikely to move the stock.

02

Market read

A routine insider sale with modest value; limited trading relevance.

03

What to watch

Potential future insider activity or larger secondary offerings could change relevance.

Relevance 4/10Novelty 3/10Timing: post-filing today

Background

SEC Form 4 filing discloses a director's sale of 13,500 shares at $30.058 per share, totaling $405,783.

Market effects

none

none

none

Counterpoint

The sale size is modest and unlikely to affect price; investors may ignore.

Key entities

  • HOME BANCSHARES INC

    Issuer of the Form 4 filing.

  • Allison John W II

    Director and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HOMBMed

Home BancShares (HOMB) Q3 2026 Earnings Call Transcript

Home BancShares (HOMB) reported Q3 2026 earnings, highlighting a 9.5% dividend increase to $0.23/share, $39.3M in share buybacks (0.69% yield), and strong profitability. The company emphasized its disciplined balance sheet strategy, avoiding long-duration securities, and managing AOCI impact. Key metrics include a 4.53% net interest margin, 2.11% ROA, and 16.54% return on tangible common equity. Management expects recoveries on a large nonperforming loan and plans continued stock repurchases.

$HOMBMed

Piper Sandler lowers Home Bancshares price target to $34 on growth

Piper Sandler cut its price target on Home Bancshares (HOMB) to $34 from $36, citing Q3 2026 results that beat EPS estimates but showed loan and deposit declines. The firm adjusted EPS estimates for 2026-2028, highlighting improved net interest margin and share repurchases. HOMB reported record Q3 earnings of $129.1M ($0.65 EPS), beating estimates, but revenue missed expectations. Analysts focus on strong profitability and capital levels.

$HOMBMed

Home BancShares (HOMB) Q3 Results Meet Record Profit While Credit Risk Builds

Home BancShares (HOMB) reported Q3 results meeting record profits, with $850M in loan production and a 4.53% margin. Management is cautiously optimistic about Q4 growth but acknowledges volatility in loan demand and deposit competition. Concerns include unpredictable loan payoffs and reliance on acquisitions for growth. The company's stock is discussed in the context of potential mispricing.

$HOMBMed

Home BancShares Q3 Earnings Call Highlights

Home BancShares (HOMB) reported Q3 earnings, including a 9.5% dividend increase to $0.23 per share and $39.3M in share repurchases. The company expects to complete Mountain Commerce integration by Q4, with $5M in annualized cost savings. Loan production was $850M, with loan growth expected to improve. Legacy deposits declined by $358M. Management anticipates resolving a large Texas C&I nonaccrual credit, potentially recovering $10M.